SEC 13F Intelligence

Managers / Q2 2022 · view latest →

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

CIK 0001553936 · SUITES 818-822, 8/F, BANK OF AMERICA, TOWER, 12 HARCOURT ROAD,, HONG KONG, K3, XXXXX · 852-3983-6800

Reported Value
$1.4B
Q2 2022
Positions
27
Filings on Record
29
2019–present window
Filed
Aug 15, 2022
original filing

Summary

Tybourne Capital Management (Hk) Ltd reported $1.4B in U.S.-listed holdings across 27 positions for Q2 2022.

Its largest position, MSFT, represents 8.1% of the portfolio.

Compared with Q1 2022, the fund opened 0 new positions and exited 3.

Portfolio Metrics

Turnover
+6.6%
vs prior filed quarter
Top-10 Concentration
+62.5%
share of reported value
Largest Position
+8.1%
Microsoft Corp Msft US

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.2BQ4 ’18Q1 ’19: $2.6BQ2 ’19: $2.8BQ3 ’19: $2.3BQ4 ’19: $2.6BQ4 ’19Q1 ’20: $2.7BQ2 ’20: $3.3BQ3 ’20: $4.1BQ4 ’20: $4.8BQ4 ’20Q1 ’21: $4.6BQ2 ’21: $4.7BQ3 ’21: $4.0BQ4 ’21: $3.4BQ4 ’21Q1 ’22: $1.7BQ2 ’22: $1.4BQ3 ’22: $1.0BQ4 ’22: $1.0BQ4 ’22Q1 ’23: $993MQ2 ’23: $925MQ3 ’23: $716MQ4 ’23: $671MQ4 ’23Q1 ’24: $585MQ2 ’24: $492MQ3 ’24: $357MQ4 ’24: $398MQ4 ’24Q1 ’25: $24MQ2 ’25: $35MQ3 ’25: $31Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 68.2%ADR: 16.7%Other: 15.1%
  • Common Stock · 68.2% · $944M
  • ADR · 16.7% · $231M
  • Other · 15.1% · $209M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AMZNAMAZON.COM INC (AMZN US)ADDED+971.7K1.01M−$24M$107M
SHOPSHOPIFY INC - CLASS A (SHOP US)ADDED+1.37M1.47M−$18M$46M
HTHTHUAZHU GROUP LTD-ADR (HTHT US)ADDED+945.1K1.78M+$40M$68M
TWLOTWILIO INC - A (TWLO US)ADDED+267.9K504.3K+$3M$42M
EQRX INC (EQRX US)SOLD OUT−2.29M0−$9M$0
RENEO PHARMACEUTICALS INC (RPHM US)SOLD OUT−700.0K0−$2M$0
XCUREXICURE INC (XCUR US)SOLD OUT−7.33M0−$1M$0
SESEA LTD-ADR (SE US)ADDED+257.6K867.3K−$15M$58M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

27 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MSFTMICROSOFT CORP (MSFT US)history →COM8.11%$112M437.4K
2CANADIAN PACIFIC RAILWAY LTD (CP US)COM8.01%$111M1.59M
3AMZNAMAZON.COM INC (AMZN US)history →COM7.76%$107M1.01M
4VVISA INC-CLASS A SHARES (V US)history →COM CL A7.28%$101M511.7K
5SPGIS&P GLOBAL INC (SPGI US)history →COM6.52%$90M267.8K
6BEKEKE HOLDINGS INC-ADR (BEKE US)history →SPONSORED ADS5.72%$79M4.41M
7ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)history →COM4.92%$68M2.43M
8HTHTHUAZHU GROUP LTD-ADR (HTHT US)history →SPONSORED ADS4.90%$68M1.78M
9MELIMERCADOLIBRE INC (MELI US)history →COM4.85%$67M105.4K
10LINDE PLC (LIN US)SHS4.47%$62M215.3K
11SESEA LTD-ADR (SE US)history →SPONSORD ADS4.19%$58M867.3K
12SHOPSHOPIFY INC - CLASS A (SHOP US)history →CL A3.31%$46M1.47M
13TXNTEXAS INSTRUMENTS INC (TXN US)history →COM3.21%$44M289.2K
14QCOMQUALCOMM INC (QCOM US)history →COM3.20%$44M346.8K
15LAM RESEARCH CORP (LRCX US)COM3.11%$43M101.0K
16TWLOTWILIO INC - A (TWLO US)history →CL A3.05%$42M504.3K
17XYZBLOCK INC (SQ US)history →CL A2.78%$38M625.9K
18ATLASSIAN CORP PLC-CLASS A (TEAM US)CL A2.60%$36M192.1K
19MDBMONGODB INC (MDB US)history →CL A2.47%$34M132.0K
20STNESTONECO LTD-A (STNE US)history →COM CL A2.15%$30M3.86M
21SNOWSNOWFLAKE INC-CLASS A (SNOW US)history →CL A1.84%$26M183.6K
22NVDANVIDIA CORP (NVDA US)history →COM1.77%$24M161.6K
23BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)history →SPONSORED ADS1.40%$19M1.15M
24AMLXAMYLYX PHARMACEUTICALS INC (AMLX US)history →COM1.07%$15M768.6K
25INHIBRX INC (INBX US)COM0.65%$9M794.7K
26LIANYLIANBIO-ADR (LIAN US)SPONSORED ADS0.52%$7M3.31M
27TSHATAYSHA GENE THERAPIES INC (TSHA US)COM SHS0.13%$2M500.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$31M4Nov 6, 202513F-HRchanges · EDGAR ↗
Q2 2025$35M6Aug 1, 202513F-HRchanges · EDGAR ↗
Q1 2025$24M5May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$398M37Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$357M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$492M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$585M41May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$671M39Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$716M41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$925M49Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$993M49May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B27Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.0B26Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B27Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.7B30May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.4B26Feb 25, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$4.0B24Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$4.7B29Jul 22, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.6B32Apr 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$4.8B31Feb 11, 202113F-HRchanges · EDGAR ↗
Q3 2020$4.1B29Nov 9, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B21Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.7B21May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$2.6B13Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.3B12Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$2.8B13Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$2.6B11May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.2B9Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.